The New Era in Alzheimer’s Disease: Integrating Diagnostic Biomarkers and ATTs

Diagnosing Alzheimer’s Disease in the Biomarker Era: Promises and Pitfalls | Professor Ron PetersenПодробнее

New Era for Alzheimer’s Disease?Подробнее

Diagnosis of Alzheimer's Disease in the Era of Biomarkers - Ronald C. Petersen, MD, PhDПодробнее

Beyond Aβ and p-Tau: novel biomarkers under investigation for Alzheimer’s diseaseПодробнее

The future of diagnostics in the evolving Alzheimer’s disease care landscapeПодробнее

Early detection and new biomarkers for Alzheimer’s diseaseПодробнее

Biomarker Changes Preceding Alzheimer’s Disease | NEJMПодробнее

The New Era of ATTs in Alzheimer's Disease: Key Evidence, Considerations, and Best PracticesПодробнее

Decoding #Alzheimer's Disease : The Truth Behind Blood #BiomarkersПодробнее

Access to Alzheimer’s disease diagnostic biomarkers in clinical routineПодробнее

Applying Fluid Biomarkers to Facilitate the Accurate Neuropathological Diagnosis of ADПодробнее

Dementia education I The who, what, where and when of Alzheimer’s disease biomarker testingПодробнее

Advances in Biomarkers and Treatment of Alzheimer's DiseaseПодробнее

Diagnosis and Treatment in a New Era for DementiaПодробнее

Diagnostic biomarkers on the horizon in Alzheimer’s diseaseПодробнее

Redefining Alzheimer's Disease: New Diagnostic CriteriaПодробнее

Diagnosing Alzheimer’s disease using blood-based biomarkersПодробнее

Blood Biomarker Challenge - There are two complementary research projects joining the challengeПодробнее

How Are Blood-Based Biomarkers Reshaping Alzheimer’s Disease Diagnostics and Treatment?Подробнее